** Shares of EMVision Medical Devices rise as much as 17.7% to A$2.1, their best trading session since early March
** Shares hit their highest level since Oct. 22
** Medical equipment and tech co reports successful results from its neurodiagnostic technology for early identification of stroke and stroke types
** Says study highlights sensing capabilities, including successful detection and classification of very small haemorrhages
** Adds AI-based diagnostic models demonstrated improved performance as additional clinical data was provided
** More than 78,000 shares change hands vs 30-day avg volume of around 35,000 shares
** YTD, EMV up 21.5% as of 0100 GMT
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。